Arthritis drug reduces mortality in severe COVID-19, huge clinical trial finds | Science
Baricitinib, an oral drug that dampens an overactive immune system and is commonly used by people with rheumatoid arthritis, reduced hospitalized COVID-19 patients’ risk of dying by 13%, investigators of the world’s largest trial of coronavirus treatments announced today. Patients in the study also took other drugs, such as the steroid dexamethasone, that act on … Read more